Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

IRTC

iRhythm Technologies Inc

Sep 12 • 04:00PM ET

179.82

-1.21 -0.67 %

Healthcare • Medical Devices • USA • NASD

Peers: ISRG DXCM TDOC ALGN VEEV BIO PODD STM QDEL JAZZ

| Held by: IWM VTI VB VBK IWO VXF IHI SCHA VTWO KOMP

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.94	Insider Own	1.91%	Shs Outstand	32.10M	Perf Week	-0.68%
Market Cap	5.78B	Forward P/E	-	EPS next Y	-0.52	Insider Trans	-9.76%	Shs Float	31.51M	Perf Month	7.77%
Enterprise Value	5.97B	PEG	-	EPS next Q	-0.33	Inst Own	110.99%	Short Float	8.81%	Perf Quarter	23.60%
Income	-92.43M	P/S	8.79	EPS this Y	53.70%	Inst Trans	-1.95%	Short Ratio	6.06	Perf Half Y	83.92%
Sales	657.23M	P/B	55.69	EPS next Y	68.83%	ROA	-9.82%	Short Interest	2.78M	Perf YTD	99.42%
Book/sh	3.23	P/C	10.59	EPS next 5Y	-	ROE	-91.13%	52W High	187.57 -4.13%	Perf Year	148.34%
Cash/sh	16.98	P/FCF	207.23	EPS past 3/5Y	-1.67% -10.95%	ROIC	-11.24%	52W Low	55.92 221.57%	Perf 3Y	12.09%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	22.39% 22.50%	Gross Margin	69.78%	Volatility	2.60% 2.83%	Perf 5Y	-15.35%
Dividend TTM	-	EV/Sales	9.08	EPS Y/Y TTM	31.14%	Oper. Margin	-10.37%	ATR (14)	5.04	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.88	Sales Y/Y TTM	22.37%	Profit Margin	-14.06%	RSI (14)	63.31	Recom	1.21
Dividend Gr. 3/5Y	- -	Current Ratio	5.02	EPS Q/Q	31.16%	SMA20	4.30%	Beta	1.16	Target Price	182.62
Payout	-	Debt/Eq	7.09	Sales Q/Q	26.10%	SMA50	15.39%	Rel Volume	0.51	Prev Close	181.03
Employees	2000	LT Debt/Eq	6.93	Earnings	Jul 31 AMC	SMA200	45.58%	Avg Volume	458.32K	Price	179.82
IPO	Oct 20, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	9.17% 7.30%	Trades		Volume	232,423	Change	-0.67%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-20-25	Initiated	BofA Securities	Buy	$200
May-02-25	Upgrade	Wells Fargo	Equal Weight → Overweight	$130
Dec-03-24	Resumed	Wells Fargo	Equal Weight	$86
Oct-04-24	Initiated	Goldman	Neutral	$78
Jun-20-24	Upgrade	Wolfe Research	Peer Perform → Outperform	$115
Dec-11-23	Upgrade	Citigroup	Neutral → Buy	$110
Jul-19-23	Initiated	Robert W. Baird	Outperform	$130
Feb-07-23	Initiated	Wells Fargo	Overweight	$150
Nov-07-22	Upgrade	Wolfe Research	Underperform → Peer Perform
Jun-09-22	Downgrade	Citigroup	Buy → Neutral	$180 → $155
Apr-06-22	Initiated	Wolfe Research	Underperform	$105
Feb-24-22	Upgrade	Needham	Hold → Buy	$135
Feb-24-22	Upgrade	Needham	Hold → Buy
Jan-18-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$129 → $167
Jan-12-22	Upgrade	BTIG Research	Neutral → Buy	$170
Jan-11-22	Upgrade	Oppenheimer	Perform → Outperform	$150
Dec-21-21	Resumed	Canaccord Genuity	Buy	$125
Dec-17-21	Upgrade	JP Morgan	Neutral → Overweight	$100 → $116
Dec-15-21	Upgrade	Citigroup	Neutral → Buy	$120
Jun-02-21	Downgrade	Citigroup	Buy → Neutral	$105 → $78

Show Previous Ratings

Sep-12-25 08:34AM	IRhythm Technologies (IRTC) Surged on Continued Momentum in Mobile Cardiac Telemetry (Insider Monkey)
Sep-11-25 12:39AM	3 Overrated Stocks with Open Questions (StockStory)
Sep-02-25 01:32PM	IRTC Unveils Positive AMALFI Trial Data Showing Higher AF Detection (Zacks)
Sep-01-25 12:01AM	iRhythm (IRTC): Buy, Sell, or Hold Post Q2 Earnings? (StockStory)
Aug-29-25 07:00AM	AMALFI Randomized Clinical Trial Results Demonstrate Increased Atrial Fibrillation Diagnosis with Home-Based Long-Term Continuous ECG Monitoring Using iRhythm Technologies' Zio LTCM Service (GlobeNewswire)
09:03AM	Loading…
Aug-22-25 09:03AM	Solid Earnings Lifted iRhythm Technologies (IRTC) in Q2 (Insider Monkey)
Aug-20-25 04:30PM	iRhythm Technologies to Participate in Upcoming Investor Conferences (GlobeNewswire)
12:34AM	iRhythm Technologies (IRTC) Surpasses Q2 Revenue Forecasts, Raises Outlook (Insider Monkey)
Aug-18-25 09:00AM	Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Sell Research Opinion on iRhythm Technologies (NASDAQ: IRTC) (Business Wire)
08:05AM	AVALON Real-World Evidence Builds on CAMELOT Study Reinforcing iRhythm's Zio LTCM Clinical Superiority (GlobeNewswire)
Aug-13-25 03:00PM	Tempus AI Stock Jumps Post Q2 as EBITDA Breakeven Nears: Buy or Hold? (Zacks)
12:08AM	IRTC Q2 Deep Dive: Core Business Momentum and Product Expansion Shape Outlook (StockStory)
12:05AM	5 Must-Read Analyst Questions From iRhythm's Q2 Earnings Call (StockStory)
Aug-01-25 12:21PM	iRhythm (IRTC) Stock Trades Up, Here Is Why (StockStory) +17.68%
03:37AM	iRhythm Technologies Inc (IRTC) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
05:40PM	Loading…
Jul-31-25 05:40PM	iRhythm Technologies (IRTC) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:54PM	iRhythm (NASDAQ:IRTC) Delivers Strong Q2 Numbers, Stock Soars (StockStory)
04:10PM	iRhythm and Lucem Health Partner to Introduce Predictive AI Solution for Early Detection of Arrhythmias in Patient Populations with Comorbid Conditions (GlobeNewswire)
04:05PM	iRhythm Technologies Announces Second Quarter 2025 Financial Results (GlobeNewswire)
12:33PM	FDA Clearance Boosts iRhythm Zio Device Innovation and Fuels Growth Potential (Insider Monkey)
Jul-29-25 11:11PM	What To Expect From iRhythm's (IRTC) Q2 Earnings (StockStory)
Jul-28-25 10:00AM	Hims & Hers Health, Inc. (HIMS) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Jul-24-25 10:00AM	Will iRhythm Technologies (IRTC) Report Negative Earnings Next Week? What You Should Know (Zacks)
Jul-23-25 08:44AM	Tempus AI Gains FDA Nod Amid Booming AI ECG Market Momentum (Zacks)
Jul-17-25 04:30PM	iRhythm Technologies to Report Second Quarter 2025 Financial Results on July 31, 2025 (GlobeNewswire)
03:00PM	TEM Shares Surge on New AI Breakthrough: Should Investors Jump In? (Zacks)
Jul-15-25 08:45AM	Artificial Intelligence Revolutionizing Early Detection of Diabetic Retinopathy Creating a Multi-Billion Dollar Revenue Opportunity (PR Newswire)
Jul-14-25 03:21PM	iRhythm (IRTC) Stock Trades Up, Here Is Why (StockStory)
Jul-11-25 01:34AM	5 Revealing Analyst Questions From iRhythm's Q1 Earnings Call (StockStory)
Jul-10-25 04:52PM	Integer Appoints Michael Coyle to Board of Directors (GlobeNewswire)
08:30AM	Loading…
Jul-07-25 08:30AM	iRhythm Technologies Announces Board Member Retirements and New Director Appointments (GlobeNewswire)
Jun-29-25 11:32PM	Patient Monitoring Stocks Q1 In Review: iRhythm (NASDAQ:IRTC) Vs Peers (StockStory)
Jun-27-25 12:03AM	3 Reasons IRTC is Risky and 1 Stock to Buy Instead (StockStory)
Jun-23-25 08:30AM	New Data Presented at ADA 2025 Highlights Burden and Risk Associations of Cardiac Arrhythmias in Patients with Type 2 Diabetes and Chronic Kidney Disease (GlobeNewswire)
Jun-19-25 07:21AM	DOCS vs. IRTC: Who Will Win High-Stakes AI Showdown in Digital Health? (Zacks)
Jun-09-25 03:00PM	Innovation Fuels Rally for Tempus AI: Should You Buy the Stock Today? (Zacks)
May-21-25 04:45PM	iRhythm Technologies to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-16-25 06:45AM	IRTC Q1 Earnings Call: Outperformance Driven by Zio AT and Primary Care Channel Expansion (StockStory)
May-15-25 03:00PM	After 92% YTD Surge, Is Tempus AI a Buy on Trump's Executive Order? (Zacks)
May-11-25 05:25PM	Why iRhythm Technologies (IRTC) Is Among the Best Performing Healthcare Stocks to Buy Now (Insider Monkey)
May-06-25 03:20PM	Veracyte Stock Earns Relative Strength Rating Upgrade (Investor's Business Daily)
May-05-25 02:48PM	Progyny Stock Sees RS Rating Improve To 73 (Investor's Business Daily)
May-02-25 03:17AM	iRhythm Technologies Inc (IRTC) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... (GuruFocus.com) +20.75%
May-01-25 09:14PM	iRhythm Technologies, Inc. (IRTC) Q1 2025 Earnings Call Transcript (Seeking Alpha)
05:45PM	IRhythm Technologies (IRTC) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:10PM	iRhythm Launches Zio Long-Term Continuous Monitoring Service in Japan as the Zio ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection (GlobeNewswire)
04:05PM	iRhythm Technologies Announces First Quarter 2025 Financial Results (GlobeNewswire)
Apr-29-25 06:05PM	iRhythm Technologies to Present at the Bank of America Securities 2025 Health Care Conference (GlobeNewswire)
Apr-28-25 08:05AM	iRhythm Presents New Real-World Data on Ambulatory Cardiac Monitoring at HRS 2025 Reinforcing Clinical Superiority of Zio Long-Term Continuous Monitoring (GlobeNewswire)
Apr-25-25 04:49AM	The Zacks Analyst Blog Highlights Tempus AI, AstraZeneca, iRhythm Technologies and SOPHiA GENETICS (Zacks)
Apr-24-25 03:00PM	Tempus AI Stock Sees 21% Gain in 3 Days: Is it a Buy After AZN Deal? (Zacks)
Apr-17-25 04:30PM	iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025 (GlobeNewswire)
Apr-16-25 08:35AM	iRhythm Technologies Releases 2024 Corporate Sustainability Report That Demonstrates Ongoing Commitment to Culture of Quality and Sustainability (GlobeNewswire)
Apr-10-25 05:05AM	3 Reasons IRTC is Risky and 1 Stock to Buy Instead (StockStory)
Apr-03-25 05:09AM	Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks (StockStory)
Apr-01-25 03:00PM	Tempus AI Surges 43% YTD: Is it the Right Time to Invest in the Stock? (Zacks)
Mar-31-25 08:05AM	iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio Long-Term Continuous Monitoring for Arrhythmia Detection (GlobeNewswire)
Mar-17-25 12:00PM	iRhythm Technologies (IRTC) Upgraded to Buy: Here's What You Should Know (Zacks)
Mar-11-25 05:07AM	Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD) (StockStory) +6.03%
Mar-05-25 08:03AM	1 Growth Stock to Target This Week and 2 to Ignore (StockStory)
Feb-21-25 02:15AM	iRhythm Technologies Inc (IRTC) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com) +6.01%
Feb-20-25 11:57PM	VitalConnect raises $100M for heart monitor patch (MedTech Dive)
05:27PM	iRhythm (NASDAQ:IRTC) Reports Strong Q4, Stock Soars (StockStory)
05:25PM	IRhythm Technologies (IRTC) Beats Q4 Earnings and Revenue Estimates (Zacks)
04:05PM	iRhythm Technologies Announces Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Feb-19-25 08:01AM	iRhythm (IRTC) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
Feb-13-25 10:01AM	Will iRhythm Technologies (IRTC) Report Negative Earnings Next Week? What You Should Know (Zacks)
Feb-06-25 04:05PM	iRhythm Technologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025 (GlobeNewswire)
Jan-18-25 07:55AM	iRhythm price target raised to $125 from $112 at Needham (TipRanks)
Jan-14-25 09:05AM	iRhythm Technologies Reports Strong Growth and Innovation (TipRanks)
Jan-13-25 08:30AM	iRhythm Technologies Shares Preliminary Fourth Quarter 2024 Highlights and Business Update at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-30-24 04:30PM	iRhythm Technologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-19-24 07:30AM	iRhythm price target raised to $111 from $85 at Truist (TipRanks)
Nov-20-24 04:30PM	iRhythm Technologies to Participate in the Citi 2024 Global Healthcare Conference (GlobeNewswire)
Nov-18-24 10:00AM	Inside a $400 billion bet on the brain-computer interface revolution (Yahoo Finance)
08:15AM	iRhythm Data Presented at the American Heart Association 2024 Scientific Sessions Reinforce Clinical and Health Economic Value of Zio Long-Term Continuous Monitoring (GlobeNewswire)
Nov-05-24 04:30PM	iRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference (GlobeNewswire) +6.43%
Nov-01-24 08:49AM	Heres Why iRhythm Technologies (IRTC) Slid in Q3 (Insider Monkey)
07:45AM	FDA clears iRhythms second 510(k) in response to warning letter (MedTech Dive)
Oct-31-24 03:16AM	iRhythm Technologies Inc (IRTC) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... (GuruFocus.com)
Oct-30-24 06:35PM	IRhythm Technologies (IRTC) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
05:15PM	iRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio AT Device (GlobeNewswire)
04:08PM	iRhythm Technologies Announces Third Quarter 2024 Financial Results (GlobeNewswire)
Oct-28-24 08:02AM	Newly Published Research Shows 14-Day Monitoring Detected Almost Three Times More Nonsustained Ventricular Tachycardia Than Standard 48-Hour Monitoring in Patients with Hypertrophic Cardiomyopathy (GlobeNewswire)
Oct-23-24 07:47AM	iRhythm Technologies (IRTC) Soars 21.7%: Is Further Upside Left in the Stock? (Zacks)
06:00AM	iRhythms Zio AT design changes win FDA clearance (MedTech Dive)
Oct-22-24 01:18PM	With FDA Approval iRhythm May Be Able To Lift Regulatory Overhang, Investor Skepticism, Analyst Says (Benzinga) +21.72%
12:24PM	iRhythm's Stock Skyrockets 17% After Game-Changing FDA Approval -- Is This Just the Beginning? (GuruFocus.com)
08:56AM	iRhythm shares soar after FDA clears Zio AT device updates (Investing.com)
07:36AM	iRhythm secures 510(k) clearance for Zio device updates after FDA warning (Medical Device Network)
Oct-21-24 04:05PM	iRhythm Technologies Receives FDA 510(k) Clearance for Design Updates Previously Made to Its Zio AT Device (GlobeNewswire)
Oct-16-24 04:05PM	iRhythm Technologies to Report Third Quarter 2024 Financial Results on October 30, 2024 (GlobeNewswire)
07:57AM	iRhythm Technologies (IRTC) Slipped on Regulatory Issues (Insider Monkey)
Oct-11-24 06:57AM	Irhythm Technologies Outlines Growth and Market Leadership Strategy (TipRanks)
Oct-04-24 04:45AM	Notice to Long-Term iRhythm Technologies, Inc. (IRTC) Shareholders: Grabar Law Office Is Investigating Claims on Your Behalf (Newsfile) -5.39%
Sep-12-24 04:32AM	iRhythms Zio ECG monitoring system secures Japanese regulatory approval (Medical Device Network)
Sep-11-24 08:05AM	iRhythm Technologies Announces Japanese Regulatory Approval of the Zio ECG Monitoring System, the First Product to Deliver Arrhythmia Monitoring Service Utilizing Artificial Intelligence (GlobeNewswire)
Sep-09-24 08:05AM	iRhythm Unveils Data Demonstrating Superior Real-World Performance of Next-Generation Zio Monitor at HRX 2024 Meeting (GlobeNewswire)
Sep-04-24 07:30AM	iRhythm Technologies Enters License Agreement with BioIntelliSense for Multiparameter Sensor Technology to be Used in Ambulatory Cardiac Monitoring (GlobeNewswire)
02:00AM	iRhythms Wearable Monitor Found Heart Arrhythmias. It Didnt Stop Strokes. (Barrons.com)

iRhythm Technologies, Inc. is a digital healthcare company, which engages in the provision of design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services. It also provides solutions that detect, predict, and prevent disease. The company was founded by Uday N. Kumar in September 2006 and is headquartered in San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Wilson Daniel G.	Chief Financial Officer	Sep 03 '25	Sale	175.00	5,000	875,000	34,470	Sep 04 05:14 PM
Wilson Daniel G.	Chief Financial Officer	Sep 02 '25	Sale	167.28	737	123,285	39,470	Sep 03 04:30 PM
DANIEL WILSON	Officer	Sep 03 '25	Proposed Sale	175.00	5,000	875,000		Sep 03 04:16 PM
Shrishrimal Sumi	EVP, Chief Risk Officer	Aug 22 '25	Sale	167.12	653	109,129	34,032	Aug 22 06:27 PM
SUMI SHRISHRIMAL	Officer	Aug 22 '25	Proposed Sale	167.12	653	109,129		Aug 22 04:02 PM
Rosenbaum Marc Wade	Chief Accounting Officer	Aug 11 '25	Sale	158.93	226	35,918	10,879	Aug 12 04:39 PM
TALWALKAR ABHIJIT Y	Director	Aug 11 '25	Option Exercise	10.71	5,312	56,892	25,611	Aug 12 04:38 PM
TALWALKAR ABHIJIT Y	Director	Aug 11 '25	Sale	158.02	5,312	839,381	20,299	Aug 12 04:38 PM
ABHIJIT Y TALWALKAR	Director	Aug 11 '25	Proposed Sale	158.02	5,312	839,380		Aug 11 04:18 PM
MARC ROSENBAUM	Officer	Aug 11 '25	Proposed Sale	158.93	226	35,918		Aug 11 04:04 PM
Patterson Chad	Chief Commercial Officer	Aug 06 '25	Sale	158.97	2,555	406,168	43,667	Aug 07 04:57 PM
Blackford Quentin S.	President and CEO	Aug 05 '25	Sale	160.54	30,000	4,816,191	179,038	Aug 06 05:10 PM
CHAD PATTERSON	Officer	Aug 06 '25	Proposed Sale	158.97	2,555	406,168		Aug 06 04:05 PM
QUENTIN BLACKFORD	Officer	Aug 05 '25	Proposed Sale	160.54	30,000	4,816,191		Aug 05 05:06 PM
Smith Mervin	EVP Strategic Business Ops	Aug 04 '25	Sale	164.36	616	101,246	15,838	Aug 05 05:03 PM
Patterson Chad	Chief Commercial Officer	Aug 04 '25	Sale	164.36	2,707	444,922	46,222	Aug 05 05:02 PM
MARK JEFFREY RUBASH	Director	Aug 05 '25	Proposed Sale	160.54	15,000	2,408,109		Aug 05 04:51 PM
Turakhia Minang	EVP, CMO & CSO	Jul 02 '25	Sale	145.41	1,420	206,482	41,393	Jul 02 05:51 PM
Wilson Daniel G.	Chief Financial Officer	Jun 23 '25	Sale	150.00	3,000	450,000	40,307	Jun 24 04:16 PM
Patterson Chad	Chief Commercial Officer	Jun 23 '25	Sale	150.00	936	140,400	48,929	Jun 24 04:15 PM
DANIEL WILSON	Officer	Jun 23 '25	Proposed Sale	150.00	3,000	450,000		Jun 23 04:36 PM
CHAD PATTERSON	Officer	Jun 23 '25	Proposed Sale	150.00	936	140,400		Jun 23 04:13 PM
Patterson Chad	Chief Commercial Officer	Jun 10 '25	Sale	150.00	363	54,450	49,865	Jun 11 04:21 PM
CHAD PATTERSON	Officer	Jun 10 '25	Proposed Sale	150.00	363	54,450		Jun 10 06:06 PM
Shrishrimal Sumi	EVP, Chief Risk Officer	Jun 02 '25	Sale	140.21	1,608	225,458	34,685	Jun 03 04:18 PM
Rosenbaum Marc W.	Chief Accounting Officer	Jun 02 '25	Sale	140.21	696	97,586	11,105	Jun 03 04:17 PM
Wilson Daniel G.	Chief Financial Officer	May 02 '25	Sale	125.00	2,000	250,000	43,307	May 05 04:11 PM
Patterson Chad	Chief Commercial Officer	May 02 '25	Sale	120.55	8,510	1,025,898	49,930	May 05 04:10 PM
DANIEL WILSON	Officer	May 02 '25	Proposed Sale	125.00	2,000	250,000		May 02 04:14 PM
CHAD PATTERSON	Officer	May 02 '25	Proposed Sale	120.55	8,510	1,025,898		May 02 04:13 PM
Blackford Quentin S.	President and CEO	Mar 03 '25	Sale	108.77	8,145	885,932	208,741	Mar 04 04:05 PM
Rosenbaum Marc W.	Chief Accounting Officer	Mar 03 '25	Sale	108.77	314	34,154	11,507	Mar 04 04:05 PM
Smith Mervin	EVP Strategic Business Ops	Mar 03 '25	Sale	108.77	638	69,395	16,454	Mar 04 04:04 PM
Patterson Chad	Chief Commercial Officer	Mar 03 '25	Sale	108.77	2,756	299,770	58,440	Mar 04 04:03 PM
Shrishrimal Sumi	EVP, Chief Risk Officer	Mar 03 '25	Sale	108.77	1,726	187,737	36,117	Mar 04 04:02 PM
Turakhia Minang	EVP, CMO & CSO	Mar 03 '25	Sale	108.77	2,467	268,336	42,495	Mar 04 04:02 PM
Wilson Daniel G.	Chief Financial Officer	Mar 03 '25	Sale	108.77	2,341	254,631	45,307	Mar 04 04:01 PM
Patterson Chad	Chief Commercial Officer	Feb 26 '25	Sale	112.13	13,229	1,483,368	61,196	Feb 27 04:08 PM
Patterson Chad	Chief Commercial Officer	Feb 25 '25	Sale	118.98	461	54,850	36,761	Feb 27 04:08 PM
Shrishrimal Sumi	EVP, Chief Risk Officer	Feb 26 '25	Sale	112.13	7,942	890,536	37,843	Feb 27 04:07 PM
Turakhia Minang	EVP, CMO & CSO	Feb 26 '25	Sale	112.13	7,014	786,480	44,962	Feb 27 04:06 PM
Murphy Patrick Michael	CBO and CLO	Feb 26 '25	Sale	109.68	16,330	1,791,041	58,834	Feb 27 04:04 PM
Blackford Quentin S.	President and CEO	Feb 26 '25	Sale	112.13	22,252	2,495,117	216,886	Feb 27 04:03 PM
Wilson Daniel G.	Chief Financial Officer	Feb 26 '25	Sale	112.13	2,512	281,671	47,648	Feb 27 04:03 PM
CHAD PATTERSON	Officer	Feb 25 '25	Proposed Sale	118.98	461	54,850		Feb 25 04:00 PM
Murphy Patrick Michael	CBO and CLO	Dec 02 '24	Sale	85.89	2,492	214,038	35,327	Dec 03 03:45 PM
TALWALKAR ABHIJIT Y	Director	Nov 04 '24	Buy	75.16	6,664	500,866	18,941	Nov 05 11:59 AM
Blackford Quentin S.	President and CEO	Nov 04 '24	Sale	77.41	16,145	1,249,784	159,929	Nov 05 11:59 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

IRTC

iRhythm Technologies Inc

Upgrade your FINVIZ experience